Rp1774.20
Rp-13.55 (-0.76%)
End-of-day quote: 05/17/2024
BSE:524669
Hester Biosciences Annual Report
| Year | Year | 2024 | 2023 | 2022 | 2021 | 2014 | ||
|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
Rp3.15B | Rp2.78B | Rp2.47B | Rp2.18B | Rp690.48M | |
| GM % | Gross Margin % |
|
69.58% | 70.35% | 73.37% | 75.79% | 68.21% | |
| OM | Operating Margin |
|
14.95% | 15.11% | 22.32% | 27.16% | 28.97% | |
| EPS | Earnings Per Share |
|
Rp0.00 | Rp32.96 | Rp32.96 | Rp46.41 | Rp43.51 | Rp11.11 |
| Div. | Dividends |
|
Rp8.00 | Rp8.00 | Rp10.00 | Rp0.00 | Rp0.00 | |
| PR % | Payout Ratio % |
|
24.27% | 24.27% | 21.55% | 0 | 0 | |
| Sha. | Shares |
|
6.58m | 8.51m | 8.51m | 8.51m | 8.51m | |
| OCF | Operating Cash Flow |
|
Rp481.34M | Rp235.96M | Rp88.08M | Rp580.53M | Rp93.92M | |
| FCF | Free Cash Flow |
|
Rp237.37M | Rp-541.66M | Rp-869.02M | Rp173.11M | Rp-37.45M | |
| FCFS | Free Cash Flow Per Share |
|
Rp31.27 | Rp-63.67 | Rp-102.16 | Rp20.35 | Rp-4.40 |
